US · ZYBT
Zhengye Biotechnology Holding Limited
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Jilin 132101
- Website
- jlzybio.com
Price · as of 2024-12-31
$0.92
Market cap 37.91M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $8.50 | +823.91% |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $4.35 | $60.84 |
AI valuation
Our deep-learning model estimates Zhengye Biotechnology Holding Limited's (ZYBT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $8.50
- Current price
- $0.92
- AI upside
- +823.91%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ZYBT | Zhengye Biotechnology Hol… | $0.92 | 37.91M | +6,513% | — | — | — | — | — | — | — | — | — | 48.99% | 8.82% | 6.07% | 4.84% | 4.42% | 2.71% | 0.30 | 4.07 | 1.31 | 0.80 | 1.59 | — | -1195.00% | -6372.00% | — | 0.30 | 3.81% | — | 119.00% | — | — | — | — | — |
| APYX | Apyx Medical Corporation | $3.27 | 134.17M | +662% | -86% | — | — | -1.69 | 2.80 | 0.83 | -2.79 | -7.60 | 2.80 | 61.04% | -39.18% | -48.78% | -115.17% | -88.10% | -32.70% | 2.73 | -3.19 | 5.26 | 4.40 | -0.42 | 2222.00% | -811.00% | 22461.00% | -47.15% | -1.68 | -87.74% | 0.00% | 0.00% | 0.00% | -2.49 | -2.50 | 0.97 | -0.58 |
| ATOS | Atossa Therapeutics, Inc. | $4.43 | 38.15M | — | — | — | — | -3.65 | 1.30 | — | -0.80 | — | 1.30 | 0.00% | — | — | -31.39% | -1873.25% | -29.54% | 0.00 | — | 14.99 | 14.31 | 2.58 | -1667.00% | — | 45.00% | -22.60% | -4.23 | -1427.53% | 0.00% | 0.00% | 0.00% | -0.80 | -1.05 | — | 7.27 |
| CRDL | Cardiol Therapeutics Inc. | $1.02 | 113.91M | — | — | — | — | -3.18 | 4.71 | — | -2.15 | -19.96 | 4.71 | 0.00% | — | — | -138.47% | 660.06% | -106.99% | 0.01 | — | 4.52 | 4.41 | 0.76 | 1591.00% | — | -64.00% | -21.53% | -3.58 | 411.05% | 0.00% | 0.00% | 0.00% | -2.14 | -3.43 | — | -1.32 |
| EXOZ | eXoZymes, Inc. | $8.85 | 74.23M | — | — | — | — | -20.08 | 11.29 | — | -19.55 | -10.68 | 11.29 | 0.00% | — | — | -116.80% | -365.14% | -70.65% | 0.13 | — | 8.12 | 7.84 | 1.49 | 18800.00% | — | 50576.00% | -7.56% | -6.38 | -547.95% | 0.00% | 0.00% | 8.39% | -18.43 | -12.28 | — | 25.10 |
| IXHL | Incannex Healthcare Limit… | $4.24 | 48.7M | +3,609% | +49% | — | — | -0.39 | 1.35 | 210.33 | -0.07 | -0.04 | 1.35 | 100.00% | -27661.63% | -54517.44% | -381.09% | -1055.21% | -250.09% | 0.02 | -78.51 | 2.86 | 2.82 | 0.31 | 109298.00% | 37870.00% | -2234.00% | -69.22% | -1.79 | -577.00% | 0.00% | 0.00% | 51.39% | -0.14 | -0.26 | 38.46 | -12.32 |
| ONCY | Oncolytics Biotech Inc. | $1.13 | 113.41M | — | — | — | — | -2.33 | 12.32 | — | -1.69 | — | 12.32 | 0.00% | — | — | -189.05% | 442.22% | -107.48% | 0.18 | — | 2.82 | 2.39 | 0.43 | 0.00% | — | -440.00% | -36.90% | -4.03 | 343.91% | 0.00% | 0.00% | 0.00% | -1.68 | -2.16 | — | -35.01 |
| PDEX | Pro-Dex, Inc. | $44.31 | 144.54M | +1,328% | +5% | -44% | +89% | 13.99 | 3.43 | 1.89 | 9.56 | 4.05 | 3.43 | 29.30% | 16.05% | 13.48% | 26.60% | 19.04% | 15.80% | 0.45 | 12.89 | 3.23 | 1.68 | 1.14 | 34500.00% | 2368.00% | -15613.00% | -2.33% | -0.11 | -7.00% | 0.00% | 0.00% | 2.79% | 12.63 | -46.10 | 2.03 | 6.19 |
| SERA | Sera Prognostics, Inc. | $2.29 | 86.17M | +1,463% | -17% | — | +2,648% | -4.35 | 3.00 | 1860.23 | -3.05 | — | 3.06 | -6.49% | -47577.92% | -42724.68% | -55.78% | -289.10% | -39.16% | 0.02 | -1308.39 | 1.92 | 1.87 | 0.10 | -1466.00% | -7484.00% | -4403.00% | -10.67% | -0.57 | -120.66% | 0.00% | 0.00% | 0.82% | -2.67 | -6.40 | 1270.67 | -3.22 |
| SRZN | Surrozen, Inc. | $27.80 | 238.29M | — | -83% | — | — | -0.55 | -1.64 | 3.28 | -0.37 | -34.54 | -1.64 | 100.00% | -239.69% | -596.56% | -767.91% | 121.02% | -134.46% | -0.40 | — | 5.32 | 5.07 | 1.08 | 159.00% | — | -5669.00% | -50.45% | -2.41 | 83.66% | 0.00% | 0.00% | 0.00% | -0.35 | -0.50 | 0.84 | -8.68 |
| TIL | Instil Bio, Inc. | $8.90 | 60.36M | — | — | — | — | -1.61 | 0.70 | — | -1.48 | — | 0.70 | 0.00% | — | — | -37.51% | -48.30% | -25.16% | 0.51 | -8.18 | 15.76 | 14.35 | -1.25 | -5254.00% | — | -3603.00% | -55.11% | -7.05 | -43.15% | 0.00% | 0.00% | 0.00% | -1.26 | -1.41 | — | -3.11 |
About Zhengye Biotechnology Holding Limited
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
- CEO
- Songlin Song
- Employees
- 278
- Beta
- -4.63
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.92) − 1 = — (DCF, example).